Alcohol consumption appears to protect against non-alcoholic fatty liver disease

Alimentary Pharmacology and Therapeutics

Volumn 33, Issue 3, 2011, Pages 378-388

  Moriya, A ^a   Iwasaki, Y ^a   Ohguchi, S ^b   Kayashima, E ^b   Mitsumune, T ^b   Taniguchi, H ^a   Ikeda, F ^a   Shiratori, Y ^c   Yamamoto, K ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b Junpukai Health Maintenance Center   (Japan)

^c Miyamoto Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DRINKING BEHAVIOR; DYSLIPIDEMIA; ECHOGRAPHY; EXERCISE; FEMALE; GLUCOSE INTOLERANCE; HUMAN; HYPERTENSION; HYPERURICEMIA; JAPANESE; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; OBESITY; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE;

ADULT; ALCOHOL DRINKING; ASIAN CONTINENTAL ANCESTRY GROUP; CROSS-SECTIONAL STUDIES; FATTY LIVER; FEMALE; HUMANS; JAPAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTORS; STATISTICS AS TOPIC; TIME FACTORS; ULTRASONOGRAPHY;

EID: 78650876710     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2010.04520.x     Document Type: Article

References (34)

1. Rimm EB, Chan J, Stampfer MJ, Colditz GA, Willett WC,. Prospective study of cigarette smoking, alcohol use, and the risk of diabetes in men. BMJ 1995; 310: 555-9.
2. Conigrave KM, Hu BF, Camargo CA Jr, Stampfer MJ, Willett WC, Rimm EB,. A prospective study of drinking patterns in relation to risk of type 2 diabetes among men. Diabetes 2001; 50: 2390-5.
3. Mukamal KJ, Conigrave KM, Mittleman MA, et al. Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men. N Engl J Med 2003; 348: 109-18.
4. Tolstrup J, Jensen MK, TjÃnneland A, Overvad K, Mukamal KJ, GrÃnbaek M,. Prospective study of alcohol drinking patterns and coronary heart disease in women and men. BMJ 2006; 332: 1244-8.
5. Facchini F, Chen YD, Reaven GM,. Light-to-moderate alcohol intake is associated with enhanced insulin sensitivity. Diabetes Care 1994; 17: 115-9.
6. De Oliveira e Silva ER, Foster D, Harper MM, et al. Alcohol consumption raises HDL cholesterol levels by increasing the transport rate of apolipoproteins A-I and A-II. Circulation 2000; 102: 2347-52.
7. Pischon T, Girman CJ, Rifai N, Hotamisligil GS, Rimm EB,. Association between dietary factors and plasma adiponectin concentrations in men. Am J Clin Nutr 2005; 81: 780-6.
8. Davies MJ, Baer DJ, Judd JT, Brown ED, Campbell WS, Taylor PR,. Effects of moderate alcohol intake on fasting insulin and glucose concentrations and insulin sensitivity in postmenopausal women: a randomized controlled trial. JAMA 2002; 287: 2559-62.
9. Avogaro A, Watanabe RM, Dall'Arche A, De Kreutzenberg SV, Tiengo A, Pacini G,. Acute alcohol consumption improves insulin action without affecting insulin secretion in type 2 diabetic subjects. Diabetes Care 2004; 27: 1369-74.
10. Eckel RH, Grundy SM, Zimmet PZ,. The metabolic syndrome. Lancet 2005; 365: 1415-28.
11. Bugianesi E, Pagotto U, Manini R, et al. Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity. J Clin Endocrinol Metab 2005; 90: 3498-504.
12. Marchesini G, Marzocchi R, Agostini F, Bugianesi E,. Nonalcoholic fatty liver disease and the metabolic syndrome. Curr Opin Lipidol 2005; 16: 421-7. (Pubitemid 41017626)
13. Machado M, Cortez-Pinto H,. Non-alcoholic steatohepatitis and metabolic syndrome. Curr Opin Clin Nutr Metab Care 2006; 9: 637-42.
14. Palasciano G, Moschetta A, Palmieri VO, Grattagliano I, Iacobellis G, Portincasa P,. Non-alcoholic Fatty liver disease in the metabolic syndrome. Curr Pharm Des 2007; 13: 2193-8.
15. Hamaguchi M, Kojima T, Takeda N, et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med 2005; 143: 722-8.
16. Khashab MA, Liangpunsakul S, Chalasani N,. Nonalcoholic fatty liver disease as a component of the metabolic syndrome. Curr Gastroenterol Rep 2008; 10: 73-80.
17. Dixon JB, Bhathal PS, O'Brien PE,. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 2001; 121: 91-100.
18. Suzuki A, Angulo P, St Sauver J, Muto A, Okada T, Lindor K,. Light to moderate alcohol consumption is associated with lower frequency of hypertransaminasemia. Am J Gastroenterol 2007; 102: 1912-9.
19. Dunn W, Xu R, Schwimmer JB,. Modest wine drinking and decreased prevalence of suspected nonalcoholic fatty liver disease. Hepatology 2008; 47: 1947-54.
20. Gunji T, Matsuhashi N, Sato H, et al. Light and moderate alcohol consumptionsignificantly reduces the prevalence of fatty liver in the Japanese male population. Am J Gastroenterol 2009; 104: 2189-95.
21. Bellentani S, Saccoccio G, Costa G, et al. Drinking habits as cofactors of risk for alcohol induced liver damage. The Dionysos Study Group. Gut 1997; 41: 845-50.
22. You M, Crabb DW,. Recent advances in alcoholic liver disease II. Minireview: molecular mechanisms of alcoholic fatty liver. Am J Physiol Gastrointest Liver Physiol 2004; 287: G1-6.
23. Mumenthaler MS, Taylor JL, O'Hara R, Yesavage JA,. Gender differences in moderate drinking effects. Alcohol Res Health 1999; 23: 55-64.
24. Yajima Y, Ohta K, Narui T, Abe R, Suzuki H, Ohtsuki M,. Ultrasonographical diagnosis of fatty liver: significance of the liver-kidney contrast. Tohoku J Exp Med 1983; 139: 43-50.
25. Examination Committee of Criteria for 'Obesity Disease' in Japan; Japan Society for the Study of Obesity. New criteria for 'obesity disease' in Japan. Circ J 2002; 66: 987-92.
26. Prati D, Taioli E, Zanella A, et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med 2002; 137: 1-10.
27. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing, 2009.
28. Becker U, GrÃnbaek M, Johansen D, SÃrensen TI,. Lower risk for alcohol-induced cirrhosis in wine drinkers. Hepatology 2002; 35: 868-75.
29. Ajmo JM, Liang X, Rogers CQ, Pennock B, You M,. Resveratrol alleviates alcoholic fatty liver in mice. Am J Physiol Gastrointest Liver Physiol 2008; 295: G833-42.
30. Degrace P, Moindrot B, Mohamed I, Gresti J, Clouet P,. Moderate consumption of beer reduces liver triglycerides and aortic cholesterol deposit in LDLr-/- apoB100/100 mice. Atherosclerosis 2006; 189: 328-35.
31. You M, Considine RV, Leone TC, Kelly DP, Crabb DW,. Role of adiponectin in the protective action of dietary saturated fat against alcoholic fatty liver in mice. Hepatology 2005; 42: 568-77.
32. Becker U, Deis A, SÃrensen TI, et al. Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study. Hepatology 1996; 23: 1025-9.
33. Dasarathy S, Dasarathy J, Khiyami A, Joseph R, Lopez R, McCullough AJ,. Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study. J Hepatol 2009; 51: 1061-7.
34. Clark JM, Diehl AM,. Defining nonalcoholic fatty liver disease: implications for epidemiologic studies. Gastroenterology 2003; 124: 248-50.